Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · IEX Real-Time Price · USD
9.80
-0.14 (-1.41%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $1.56 billion as of July 2, 2024.
Market Cap
1.56B
Enterprise Value
1.14B
1-Year Change
n/a
Ranking
Category
Stock Price
$9.80
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $1.56B, a decrease of -39.48%. That is a compound annual growth rate of -46.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.56B | -39.96% |
| Dec 29, 2023 | 2.60B | 0.79% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 1.65B |
| Galapagos NV | 1.63B |
| Akero Therapeutics | 1.62B |
| Mirum Pharmaceuticals | 1.61B |
| Kura Oncology | 1.57B |
| InMode | 1.54B |
| Ligand Pharmaceuticals | 1.51B |
| Alignment Healthcare | 1.50B |